Cargando…
P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428834/ http://dx.doi.org/10.1097/01.HS9.0000969504.57824.4e |
_version_ | 1785090565028708352 |
---|---|
author | Ysebaert, Loïc Troussard, Xavier Levy, Vincent Le Calloch, Ronan Guieze, Romain Laribi, Kamel Lepretre, Stephane Sophie Michallet, Anne Leblond, Véronique Feugier, Pierre Lahjibi, Elhem Ramier, Julien Delmer, Alain |
author_facet | Ysebaert, Loïc Troussard, Xavier Levy, Vincent Le Calloch, Ronan Guieze, Romain Laribi, Kamel Lepretre, Stephane Sophie Michallet, Anne Leblond, Véronique Feugier, Pierre Lahjibi, Elhem Ramier, Julien Delmer, Alain |
author_sort | Ysebaert, Loïc |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104288342023-08-17 P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY Ysebaert, Loïc Troussard, Xavier Levy, Vincent Le Calloch, Ronan Guieze, Romain Laribi, Kamel Lepretre, Stephane Sophie Michallet, Anne Leblond, Véronique Feugier, Pierre Lahjibi, Elhem Ramier, Julien Delmer, Alain Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428834/ http://dx.doi.org/10.1097/01.HS9.0000969504.57824.4e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Ysebaert, Loïc Troussard, Xavier Levy, Vincent Le Calloch, Ronan Guieze, Romain Laribi, Kamel Lepretre, Stephane Sophie Michallet, Anne Leblond, Véronique Feugier, Pierre Lahjibi, Elhem Ramier, Julien Delmer, Alain P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY |
title | P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY |
title_full | P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY |
title_fullStr | P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY |
title_full_unstemmed | P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY |
title_short | P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY |
title_sort | p650: effectiveness of venetoclax according to the characteristics of patients with cll in monotherapy and combination with rituximab. interim analysis of real-life data from verone study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428834/ http://dx.doi.org/10.1097/01.HS9.0000969504.57824.4e |
work_keys_str_mv | AT ysebaertloic p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT troussardxavier p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT levyvincent p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT lecallochronan p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT guiezeromain p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT laribikamel p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT lepretrestephane p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT sophiemichalletanne p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT leblondveronique p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT feugierpierre p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT lahjibielhem p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT ramierjulien p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy AT delmeralain p650effectivenessofvenetoclaxaccordingtothecharacteristicsofpatientswithcllinmonotherapyandcombinationwithrituximabinterimanalysisofreallifedatafromveronestudy |